Results Announcements News Details

Krsnaa Diagnostics Ltd consolidated sales up 22.29% on year in Q2FY2026

(17-Aug-26   17:53)

Krsnaa Diagnostics Ltd share price ticked higher by 4.50% to Rs 576.1 after the company's net profit plunged by 60.33% to Rs 16.55 crore, while revenue from operations gained significantly 22.29% to Rs 235.53 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 74333.63 crore, improving 10.36%. It has eased by 0.23% over last one week and climbed by 12.68% in last one month while the market capitalization of Krsnaa Diagnostics Ltd has inched up 1.57% and 1.81% in the same period respectively. Profit before tax (PBT) of Krsnaa Diagnostics Ltd stood at Rs 22.44 crore in Q2 FY26, crashing by 18.16% year-on-year, and nosediving by 56.60% quarter-on-quarter. EBITDA came in at Rs 51 crore, gaining 6.98% YoY and expanding by 117.07% sequentially. Total expenses surged 28.20% to Rs 205.51 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 50.19 crore, going up by 13.12% YoY, while employee benefits expense was at Rs 36.06 crore, improving by 8.13% YoY. For the TTM ended FY26, revenue from operations advanced 15.74% to Rs 717.16 crore, while net profit surged by 36.54% to Rs 77.61 crore, compared to previous TTM. EBITDA jumped by 14022% to Rs 164.58 crore, and PBT jumped 46.68% to Rs 102.69 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 87.33 crore in FY26, as against Rs 24.35 crore in FY25. Krsnaa Diagnostics Ltd nosedived by 27.10% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.21% during the same period.